196 related articles for article (PubMed ID: 32312478)
1. Trends in recurrent respiratory papillomatosis treatment.
Ballestas SA; Shelly S; Soriano RM; Klein A
Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(2):109-120. PubMed ID: 32312478
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(2):82-88. PubMed ID: 35397828
[TBL] [Abstract][Full Text] [Related]
3. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2021 Jun; ():. PubMed ID: 34154795
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update.
Donne AJ; Kinshuck A
Expert Opin Pharmacother; 2021 Oct; 22(14):1901-1908. PubMed ID: 34080517
[No Abstract] [Full Text] [Related]
7. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
8. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Shehab N; Sweet BV; Hogikyan ND
Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
[TBL] [Abstract][Full Text] [Related]
9. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
10. Recurrent respiratory papillomatosis: A 2020 perspective.
Benedict JJ; Derkay CS
Laryngoscope Investig Otolaryngol; 2021 Apr; 6(2):340-345. PubMed ID: 33869767
[TBL] [Abstract][Full Text] [Related]
11. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
Bentley PL; Coulter MJ; Nelson BL
Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
[TBL] [Abstract][Full Text] [Related]
12. Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: A series of three pediatric cases and literature review.
Enrique OH; Eloy SH; Adrian TP; Perla V
Am J Otolaryngol; 2021; 42(5):103126. PubMed ID: 34175693
[TBL] [Abstract][Full Text] [Related]
13. Current diagnostic and management trends for recurrent respiratory papillomatosis.
Silverman DA; Pitman MJ
Curr Opin Otolaryngol Head Neck Surg; 2004 Dec; 12(6):532-7. PubMed ID: 15548913
[TBL] [Abstract][Full Text] [Related]
14. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
15. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
Pudszuhn A; Welzel C; Bloching M; Neumann K
Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.
Avelino MA; Zaiden TC; Gomes RO
Braz J Otorhinolaryngol; 2013; 79(5):636-42. PubMed ID: 24141682
[TBL] [Abstract][Full Text] [Related]
17. Intralesional Cidofovir: A Systematic Review of Administration Protocols and Long-term Recurrence Rates in Adult and Juvenile Recurrent Respiratory Papillomatosis.
Pamonag MZ; Seery AM; Omari AIA; Alnouri G; Sataloff RT
J Voice; 2023 Aug; ():. PubMed ID: 37620175
[TBL] [Abstract][Full Text] [Related]
18. Current and future management of recurrent respiratory papillomatosis.
Ivancic R; Iqbal H; deSilva B; Pan Q; Matrka L
Laryngoscope Investig Otolaryngol; 2018 Feb; 3(1):22-34. PubMed ID: 29492465
[TBL] [Abstract][Full Text] [Related]
19. Airway Papillomatosis: New Treatments for an Old Challenge.
Kumar N; Preciado D
Front Pediatr; 2019; 7():383. PubMed ID: 31620412
[TBL] [Abstract][Full Text] [Related]
20. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey.
Best SR; Mohr M; Zur KB
Laryngoscope; 2017 Oct; 127(10):2225-2229. PubMed ID: 28657692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
